Myricetin

Research use only, not for human use.

Myricetin is produced from the parent compound taxifolin through the (+)-dihydromyricetin intermediate and can be further processed to form laricitrin and then syringetin, both members of the flavonol class of flavonoids.

Myricetin is produced from the parent compound taxifolin through the (+)-dihydromyricetin intermediate and can be further processed to form laricitrin and then syringetin, both members of the flavonol class of flavonoids. Dihydromyricetin is frequently sold as a supplement and has controversial function as a partial GABAA receptor potentiator and treatment in Alcohol Use Disorder (AUD).

Cannabiscetin; NSC 407290

PI3K/Akt/mTOR signaling

PI3K

PI3Kγ

Cancer

——

529-44-2

318.24

C15H10O8

>98%(HPLC)

Ethanol: 20 mg/mL warmed (62.84 mM); DMSO: 63 mg/mL (197.96 mM)

O=C1C(O)=C(C2=CC(O)=C(O)C(O)=C2)OC3=C1C(O)=CC(O)=C3

3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one

(-20℃)

With Ice Pack

≥ 2 years